6 Einträge gefunden

1. Update Breast Cancer 2020 Part 5 - Moving Therapies From Advanced to Early Breast Cancer Patients

   1. Lux, Michael P
   2. Schneeweiss, Andreas
   3. Hartkopf, Andreas D
   4. Müller, Volkmar
   5. Janni, Wolfgang
   6. Belleville, Erik
   7. Stickeler, Elmar

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer:New Treatments and Implementation of Therapies with Companion Diagnostics

   1. Lüftner, Diana
   2. Schneeweiss, Andreas
   3. Hartkopf, Andreas D
   4. Müller, Volkmar
   5. Wöckel, Achim
   6. Janni, Wolfgang
   7. Ettl, Johannes

   2020 - Forschungsinformationssystem des UKE
4. Update Breast Cancer 2020 Part 1 - Early Breast Cancer:Consolidation of Knowledge About Known Therapies

   1. Schneeweiss, Andreas
   2. Hartkopf, Andreas D
   3. Müller, Volkmar
   4. Wöckel, Achim
   5. Lux, Michael P
   6. Janni, Wolfgang
   7. Ettl, Johannes

   2020 - Forschungsinformationssystem des UKE
5. Update Breast Cancer 2020 Part 3 - Early Breast Cancer

   1. Huober, Jens
   2. Schneeweiss, Andreas
   3. Hartkopf, Andreas D
   4. Müller, Volkmar
   5. Lux, Michael P
   6. Janni, Wolfgang
   7. Ettl, Johannes

   2020 - Forschungsinformationssystem des UKE
6. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2020 - Forschungsinformationssystem des UKE